Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiretroviral therapy is associated with a decrease in unintegrated HIV-1 DNA in pediatric patients

R M Donovan1, C E Bush, S M Smereck

  • 1Department of Infectious Diseases, Henry Ford Hospital, Detroit, Michigan 48202.

Journal of Acquired Immune Deficiency Syndromes
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic reprogramming of CD4⁺ T cells by Zaprinast induces HIV-1 latency reversal ex vivo.

Retrovirology·2026
Same author

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024
Same author

French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.

La Revue de medecine interne·2023
Same author

Graphene-Based Materials in Dental Applications: Antibacterial, Biocompatible, and Bone Regenerative Properties.

International journal of biomaterials·2023
Same author

Gastric outlet obstruction secondary to a wandering spleen: systematic review and surgical management of a case.

Annals of the Royal College of Surgeons of England·2023
Same author

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

Physical review letters·2022
Same journal

T lymphocyte homeostasis after HIV seroconversion.

Journal of acquired immune deficiency syndromes·1994
Same journal

Improved detection of HTLV-II antibody using a whole viral lysate-based EIA.

Journal of acquired immune deficiency syndromes·1994
Same journal

Changes in HIV risk behavior among French heterosexuals: patterns of sexual monogamy and condom use between 1988 and 1991.

Journal of acquired immune deficiency syndromes·1994
Same journal

HTLV-I-associated myelopathy in Venezuela.

Journal of acquired immune deficiency syndromes·1994
Same journal

Autoantibodies to nucleosomes in HIV-1-infected patients.

Journal of acquired immune deficiency syndromes·1994
Same journal

Seroprevalence of HIV-1 and syphilis antibodies in blood donors in Gonder, Ethiopia, 1989-1993.

Journal of acquired immune deficiency syndromes·1994
See all related articles

Unintegrated HIV-1 DNA (uDNA) reliably decreases with antiretroviral therapy in children. This study suggests uDNA is a promising marker for monitoring treatment efficacy in pediatric HIV patients.

Area of Science:

  • Virology
  • Pediatric Infectious Diseases
  • Immunology

Background:

  • Effective monitoring of antiretroviral therapy (ART) in children with human immunodeficiency virus (HIV) is crucial for optimizing treatment outcomes.
  • Current biomarkers for assessing ART efficacy in pediatric populations are limited, necessitating the evaluation of novel markers.

Purpose of the Study:

  • To investigate the impact of ART on various markers of HIV-1, including unintegrated DNA (uDNA), integrated DNA (iDNA), immune complex dissociated (ICD) p24 antigenemia, and plasma viral titer.
  • To identify reliable indicators for monitoring ART efficacy in children living with HIV-1.

Main Methods:

  • Longitudinal study of seven children initiating ART, with sample collection at baseline, 3 months, and 10 months.
  • Quantification of HIV-1 uDNA, iDNA, ICD p24 antigen, and plasma viral load at each time point.

Related Experiment Videos

  • Statistical analysis to assess changes in measured parameters following ART initiation.

    • Main Results:

    • A significant decrease in the percentage of HIV-1 uDNA was observed, from an average of 43% at baseline to 18% at 3 months (p=0.01) and 1% at 10 months.
    • HIV-1 iDNA levels remained relatively constant throughout the study period.
    • ICD p24 antigen levels showed variable responses, decreasing in three patients and remaining unchanged in four.
    • Plasma viral cultures were positive in only one child pre-therapy.

    Conclusions:

    • Measurement of HIV-1 uDNA is a reliable indicator that decreases following nucleoside-based antiretroviral therapy in children.
    • Unintegrated HIV-1 DNA shows potential as a valuable biomarker for monitoring ART efficacy in pediatric HIV management.